{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:56:32Z","timestamp":1787064992644,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jpba.2021.113964","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T16:57:02Z","timestamp":1612889822000},"page":"113964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing"],"prefix":"10.1016","volume":"197","author":[{"given":"Meng-juan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.113964_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2021.113964_bib0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jpba.2021.113964_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1142\/S0192415X09006692","article-title":"Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2\/STAT3 pathways","volume":"37","author":"Zheng","year":"2009","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jpba.2021.113964_bib0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/ijmm.2015.2074","article-title":"Puerarin ameliorates hepatic steatosis by activating the PPARalpha and AMPK signaling pathways in hepatocytes","volume":"35","author":"Kang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jpba.2021.113964_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3892\/etm.2013.1461","article-title":"Comparison between the efficacies of curcumin and puerarin in C57BL\/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet","volume":"7","author":"Wang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jpba.2021.113964_bib0030","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/ptr.6417","article-title":"Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1\/PI3K\/AKT signaling pathway and facilitating mitochondrial homeostasis","volume":"33","author":"Wang","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jpba.2021.113964_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/metabo8010017","article-title":"Study of the serum metabolomic profile in nonalcoholic fatty liver disease: research and clinical perspectives","volume":"8","author":"Gitto","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2021.113964_bib0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpba.2021.113964_bib0045","article-title":"Puerarin prevents high-fat diet-induced obesity by enriching Akkermansia muciniphila in the gut microbiota of mice","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2021.113964_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpba.2016.02.001","article-title":"Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats","volume":"123","author":"Gong","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.113964_bib0055","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/pr9000256","article-title":"Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies","volume":"8","author":"Ding","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2021.113964_bib0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2021.113964_bib0065","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00216-016-0100-1","article-title":"Metabolic profiling of ob\/ob mouse fatty liver using HR-MAS (1)H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway","volume":"409","author":"Gogiashvili","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2021.113964_bib0070","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1038\/emm.2016.123","article-title":"Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes","volume":"49","author":"Liu","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jpba.2021.113964_bib0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/15257771003740986","article-title":"Relationship between plasma uridine and insulin resistance in patients with non-insulin-dependent diabetes mellitus","volume":"29","author":"Yamamoto","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.jpba.2021.113964_bib0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1194\/jlr.M034249","article-title":"Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation","volume":"54","author":"Le","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2021.113964_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2050-6511-15-27","article-title":"Uridine prevents tamoxifen-induced liver lipid droplet accumulation","volume":"15","author":"Le","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2021.113964_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146994","article-title":"Chronic uridine administration induces fatty liver and pre-diabetic conditions in mice","volume":"11","author":"Urasaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2021.113964_bib0095","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jn\/nxaa032","article-title":"One-carbon metabolism in fatty liver disease and fibrosis: one-carbon to rule them all","volume":"150","author":"da Silva","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.jpba.2021.113964_bib0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13249","article-title":"Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency","volume":"37","author":"Sookoian","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jpba.2021.113964_bib0105","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbagen.2016.02.001","article-title":"Betaine chemistry, roles, and potential use in liver disease","volume":"1860","author":"Day","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2021.113964_bib0110","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","author":"Han","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.jpba.2021.113964_bib0115","doi-asserted-by":"crossref","first-page":"R1710","DOI":"10.1152\/ajpregu.00677.2010","article-title":"Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease","volume":"301","author":"Gentile","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jpba.2021.113964_bib0120","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/pr200047c","article-title":"A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2021.113964_bib0125","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3945\/jn.117.253815","article-title":"Oral supplementation of glutamine attenuates the progression of nonalcoholic steatohepatitis in C57BL\/6J mice","volume":"147","author":"Sellmann","year":"2017","journal-title":"J. Nutr."},{"key":"10.1016\/j.jpba.2021.113964_bib0130","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","article-title":"Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice","volume":"50","author":"Toye","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpba.2021.113964_bib0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/apt.15606","article-title":"Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis","volume":"51","author":"Cabre","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2021.113964_bib0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpba.2021.113964_bib0145","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/liv.12769","article-title":"Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans","volume":"35","author":"Mannisto","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jpba.2021.113964_bib0150","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13024","article-title":"Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature","volume":"21","author":"Watanabe","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jpba.2021.113964_bib0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut Lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jpba.2021.113964_bib0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.aohep.2019.06.020","article-title":"Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis","volume":"18","author":"Guohong","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jpba.2021.113964_bib0165","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bpg.2017.09.008","article-title":"NAFLD, Helicobacter species and the intestinal microbiome","volume":"31","author":"Casta\u00f1o-Rodr\u00edguez","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jpba.2021.113964_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10068-018-0433-y","article-title":"Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease","volume":"28","author":"Jung","year":"2019","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.jpba.2021.113964_bib0175","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41598-017-05698-y","article-title":"Fat binding capacity and modulation of the gut microbiota both determine the effect of wheat bran fractions on adiposity","volume":"7","author":"Suriano","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:10:27Z","timestamp":1760001027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":35,"alternative-id":["S0731708521000765"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113964","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.113964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113964"}}